X-linked inhibitor of apoptosis positive nuclear labeling: A new independent prognostic biomarker of breast invasive ductal carcinoma

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Zhang, Yutao ^a   Zhu, Jianhua ^a   Tang, Yun ^a   Li, Feng ^a   Zhou, Hongyuan ^a   Peng, Bofang ^a   Zhou, Chifeng ^a   Fu, Rong ^a  

^a First People's Hospital of Zigong   (China)

Author keywords

Prognosis; Smacapoptosis index; XIAP nuclear labeling

Indexed keywords

DIABLO PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MASTECTOMY; METABOLISM; MORTALITY; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL NUCLEUS; COMBINED MODALITY THERAPY; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MASTECTOMY, MODIFIED RADICAL; MITOCHONDRIAL PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79957899075     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-49     Document Type: Article

References (32)

1. Yan Y, Mahotka C, Heikaus S, Shibata T, Wethkamp N, Liebmann J, Suschek CV, Guo Y, Gabbert HE, Gerharz CD, Ramp U. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas. Br J Cancer 2004, 91(7):1349-1357. 10.1038/sj.bjc.6602127, 2409908, 15328523.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249. 10.3322/caac.20006, 19474385.
3. Lee TJ, Lee JT, Park JW, Kwon TK. Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation. Biochem Biophys Res Commun 2006, 351(4):1024-1030. 10.1016/j.bbrc.2006.10.163, 17097066.
4. Peng XH, Karna P, O'Regan RM, Liu X, Naithani R, Moriarty RM, Wood WC, Lee HY, Yang L. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol 2007, 71(1):101-111.
5. Zhang Y, Wang Y, Gao W, Zhang R, Han X, Jia M, Guan W. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo. Breast Cancer Res Treat 2006, 96(3):267-277. 10.1007/s10549-005-9080-0, 16341821.
6. Lima RT, Martins LM, Guimaraes JE, Sambade C, Vasconcelos MH. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther 2004, 11(5):309-316. 10.1038/sj.cgt.7700706, 15031723.
7. Holcik M, Gibson H, Robert G. XIAP: Apoptotic brake and promising therapeutic target. Apoptosis 2001, 6(4):253-261. 10.1023/A:1011379307472, 11445667.
8. Bilim V, Kasahara T, Hara N, Takahashi K, Tomita Y. Role of XIAP in the malignant phenotype of transitional cell cancer(TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer 2003, 103(1):29-37. 10.1002/ijc.10776, 12455050.
9. Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ, Kaufmann SH. Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and clAP1 in Situ. J Biol Chem 2002, 277(46):44236-44243. 10.1074/jbc.M207578200, 12218061.
10. Sun H, Nikolovska-Coleska Z, Lu J, Qiu S, Yang CY, Gao W, Meagher J, Stuckey J, Wang S. Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic. J Med Chem 2006, 49(26):7916-7920. 10.1021/jm061108d, 17181177.
11. Zobel K, Wang L, Varfolomeev E, Franklin MC, Elliott LO, Wallweber HJ, Okawa DC, Flygare JA, Vucic D, Fairbrother WJ, Deshayes K. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. ACS Chem Biol 2006, 1(8):525-33. Erratum in: ACS Chem Biol 2006 1 (9):601., 10.1021/cb600276q, 17168540.
12. Bockbrader KM, Tan M, Sun Y. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene 2005, 24(49):7381-7388. 10.1038/sj.onc.1208888, 16044155.
13. Nielsen TO, Hsu FD, O'Connell JX, Gilks CB, Sorensen PH, Linn S, West RB, Liu CL, Botstein D, Brown PO, van de Rijn M. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 2003, 163:1449-1456. 10.1016/S0002-9440(10)63502-X, 1868308, 14507652.
14. Rajcan-Separovic E, Liston P, Lefebvre C, Korneluk RG. Assignment of human inhibitor of apoptosis protein(IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluoreseence in situ hybridization. Genomics 1996, 37(3):404-406. 10.1006/geno.1996.0579, 8938457.
15. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou Q, Sun C, Fesik SW, Liddington RC, Salvesen GS. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001, 104(5):791-800. 10.1016/S0092-8674(01)00274-4, 11257232.
16. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC. Expression and prognostic significance of IAP family genes in human cancers and myeloid leukemias. Clinical Cancer Research 2000, 6(5):1796-1803.
17. Shi Z, Liang YJ, Chen ZS, Wang XH, Ding Y, Chen LM, Fu LW. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncol Rep 2007, 17(4):969-976.
18. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003, 63(20):6815-6824.
19. Nomura T, Mimata H, Takeuchi Y, Yamamoto H, Miyamoto E, Nomura Y. The X-linked inhibitor of apoptosis protein inhibits taxol induced apoptosis in LNCaP cells. Urol Research 2003, 31(1):37-44.
20. Du CY, Li YC. Smac: a mitochondrial protein that promotes cytochrome C-independent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42. 10.1016/S0092-8674(00)00008-8, 10929711.
21. Hasenjager A, Gillissen B, Muller A, Normand G, Hemmati PG, Schuler M, Dorken B, Daniel PT. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Oncogene 2004, 23(26):4523-4535. 10.1038/sj.onc.1207594, 15064710.
22. Huang Y, Rich RL, Myszka DG, Wu H. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac. J Biol Chem 2003, 278(49):49517-49522. 10.1074/jbc.M310061200, 14512414.
23. Anne M, Verhagen E. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP protein. Cell 2000, 102:43-53. 10.1016/S0092-8674(00)00009-X, 10929712.
24. Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T, Alnemri ES. Inhibitor of apoptosis proteins are substrates for the mitochondrial sorine protease Omi/HtrA2. J Biolo Chem 2003, 278(34):31469-31472.
25. Yoo NJ, Kim HS, Kim SY, Park WS, Park CH, Jeon HM, Jung ES, Lee JY, Lee SH. Immunohistochemical Analysis of Smac/DIABIO Exprcssion in Human Carcinomas and Sarcomas. APMIS 2003, 111(3):382-388. 10.1034/j.1600-0463.2003.t01-1-1110202.x, 12752217.
26. Hinnis AR, Luckett JC, Walker RA. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br J Cancer 2007, 96(4):639-645. 10.1038/sj.bjc.6603616, 2360044, 17285125.
27. Ramp U, Krieg T, Caliskan E, Mahotka C, Ebert T, Willers R, Gabbert HE, Gerharz CD. XIAP expression is an independent prognostic marker in clear cell renal carcinoma. Hum Pathol 2004, 35(8):1022-1028. 10.1016/j.humpath.2004.03.011, 15297970.
28. Jaffer S, Orta L, Sunkara S, Sabo E, Burstein DE. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma. Hum Pathol 2007, 38(6):864-870. 10.1016/j.humpath.2006.11.016, 17350670.
29. Brennan DJ, Rexhepaj E, O'Brien SL, McSherry E, O'Connor DP, Fagan A, Culhane AC, Higgins DG, Jirstrom K, Millikan RC, Landberg G, Duffy MJ, Hewitt SM, Gallagher WM. Altered cytoplasmic- to-nuclear ratio of survivin is a prognostic indicator in breast cancer. Clin Cancer Res 2008, 14(9):2681-2689. 10.1158/1078-0432.CCR-07-1760, 18451232.
30. Yin W, Chen N, Zhang Y, Zeng H, Chen X, He Y, Wang X, Zhou Q. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Modern Pathology 2006, 19:1487-1497.
31. Schöndorf T, Göhring UJ, Becker M, Hoopmann M, Schmidt T, Rützel S, Rein DT, Ulrich U, Fechteler R, Bersch A, Mallmann P, Valter MM. High apoptotic index correlates to p21 and p27 expression indicating a favorable outcome of primary breast cancer patients, but lacking prognostic significance in multivariate analysis. Pathobiology 2004, 71(4):217-222. 10.1159/000078676, 15263811.
32. Sirvent JJ, Aguilar MC, Olona M, Pelegrí A, Blázquez S, Gutiérrez C. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study. Histol Histopathol 2004, 19(3):759-770.